- $342.10m
- -$617.86m
- $600.67m
- 76
- 69
- 24
- 56
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 674 | 750 | 836 | 734 | 601 |
Cost of Revenue | |||||
Gross Profit | 430 | 532 | 631 | 542 | 455 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 768 | 677 | 738 | 747 | 688 |
Operating Profit | -94.4 | 73 | 97.3 | -12.8 | -87.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -70.1 | 96.7 | 132 | 40.6 | -5.65 |
Provision for Income Taxes | |||||
Net Income After Taxes | -98.5 | -36.5 | 69.3 | -17.3 | -66.1 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -149 | -86.1 | 928 | -17.3 | -30.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -149 | -86.1 | 928 | -17.3 | -30.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -3.49 | -1.39 | 1.76 | -0.274 | -1.81 |